This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

MMG Partners With Remedy Health Media To Bolster Clinical Trial Enrollment

ROCKVILLE, Md., Oct. 16, 2012 /PRNewswire/ -- MMG ( www.mmgct.com), a global health communications company specializing in clinical trial patient recruitment and retention, has formed an exclusive partnership with Remedy Health Media ( www.remedyhealthmedia.com) to deliver unique access to a larger pool of qualified potential clinical trial participants. Remedy Health Media (Remedy) is America's fastest growing health information and technology company, which produces a variety of clinical and wellness resources including Remedy's Healthy Living and Diabetes Focus and maintains publishing partnerships with globally recognized institutions such as Johns Hopkins Medicine and the University of California, Berkeley School of Public Health.

This partnership offers significant value to MMG's clients by effectively reaching their desired audiences through Remedy's community of more than 150 million health-information-seeking patients and caregivers. Remedy's 28.4 million unique monthly visitors (comScore, September 2012) proactively seek treatment options for therapeutic areas that match MMG's category coverage.

Additional benefits for MMG's clients include:

  • Guaranteed increase in already-high number of patient referrals;
  • Strengthened patient retention rate through Remedy's HIPAA-compliant, proprietary mobile content and adherence tools; and
  • Exclusive media placement capabilities.

"We were drawn to this partnership with Remedy because we want to be able to provide information to patients faster while offering our clients even higher value for their investment," said John Benbrook, CEO of MMG. "We look forward to leveraging MMG's unique presence within Remedy's expansive network of trusted health resources to deliver even greater measurable results."  

Michael Cunnion, CEO of Remedy Health Media, said, "We're thrilled to partner with MMG because this is a perfect opportunity to provide better information, tools and connectivity to patients who are actively seeking clarity in the trial enrollment process."

About Remedy Health MediaRemedy Health Media is a privately held health information and technology company with tools that help millions of patients and caregivers live healthier, more fulfilled lives. Remedy Health Media aims to empower lives with the information and applications needed to efficiently navigate the healthcare landscape, and as a result, to permit better health outcomes through use of our products and services.

About MMG MMG is the premier global health communications organization specializing in patient recruitment and retention. With experience in more than 70 countries and across a vast range of therapeutic areas, populations, and study types, MMG provides strategies specially crafted for study teams and patient populations while delivering the best return on investment for the sponsor. MMG, a Ketchum company, is a part of Diversified Agency Services, a division of Omnicom Group Inc.

About Diversified Agency ServicesDiversified Agency Services (DAS), a division of Omnicom Group Inc. (NYSE: OMC) ( www.omnicomgroup.com), manages Omnicom's holdings in a variety of marketing communications disciplines. DAS includes over 200 companies, which operate through a combination of networks and regional organizations, serving international and local clients through more than 700 offices in 71 countries.

About Omnicom Group Inc.Omnicom Group Inc. ( www.omnicomgroup.com) is a leading global marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations, and other specialty communications services to over 5,000 clients in more than 100 countries.

SOURCE MMG

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs